Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,897 signal articles · 187 in last 24h · 157,635 total before filter · latest 3h ago
187last 24h
865last 7d
139● bullish (7d)
81● bearish (7d)
214publishers
AllMacro196Earnings142M&A102Regulatory18Product16Analyst24
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Reasons to Avoid AIZ and 1 Stock to Buy Instead
StockStory41d agobullish
3 Reasons to Avoid AIZ and 1 Stock to Buy Instead

Assurant has had an impressive run over the past six months as its shares have beaten the S&P 500 by 14.9%. The stock now trades at $281.22, marking a 28% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Value Investing Legend Howard Marks Is Buying This Stock Down 30%. Should You Buy?
Insider Monkey41d agobullish
Value Investing Legend Howard Marks Is Buying This Stock Down 30%. Should You Buy?

Billionaire Howard Marks is one of the most respected value investors alive. He co-founded Oaktree Capital and is famous for his investor memos, the ones Warren Buffett says he reads first. His fund recently disclosed a new position in Sea Limited (NYSE:SE) worth about $60.9 million. Sea is a Southeast Asian tech company. It runs […]

Klarna shares sink as weak guidance overshadows Q2 beat
Proactive41d agobullish
Klarna shares sink as weak guidance overshadows Q2 beat

Klarna Group PLC (NYSE:KLAR) shares fell 20.5% Tuesday morning after the buy-now-pay-later company issued full-year guidance that fell short of analyst estimates, overshadowing a second-quarter earnings beat. The company reported second-quarter revenue of $1.04 billion, up 27% year-over-year...

Michael Burry is Bullish on This Beaten-Down Healthcare Stock. Time to Buy?
Insider Monkey41d agobullish
Michael Burry is Bullish on This Beaten-Down Healthcare Stock. Time to Buy?

Zoetis (NYSE:ZTS) is an animal health company. Michael Burry is long the stock, several media outlets reported, citing his Substack disclosures. The stock is down about 40% so far this year. Let’s break down whether it’s worth buying. Why Burry Likes It Burry’s pitch is simple. Zoetis has dropped more than 70% from its 2021 […]

Home Depot beats quarterly estimates on smaller project demand
Proactive41d agobullish
Home Depot beats quarterly estimates on smaller project demand

Home Depot Inc (NYSE:HD, XETRA:HDI) on Tuesday reported second-quarter sales and profit that topped Wall Street estimates, as demand for smaller home improvement projects helped drive comparable sales higher. The home improvement retailer posted sales of $47.9 billion, up 5.7% from a year...

Goldman Sachs Agrees Deal to Buy LCN Capital Partners for Up to $410 Million
InvestorsHub41d agobullish
Goldman Sachs Agrees Deal to Buy LCN Capital Partners for Up to $410 Million

Goldman Sachs Group Inc (NYSE:GS) has agreed to acquire real estate investment manager LCN Capital Partners in a transaction potentially worth as much as $410 million, expanding its capabilities in sale-leaseback, build-to-suit and triple net lease investments. LCN managed approximately $3 billion in assets as of June 30, 2026 and operates across North America and Europe, combining expertise in corporate credit with real estate investing.

Bond yields spike worldwide on top of soaring debt, AI spending
Yahoo Finance Video41d agobullishVIDEO
Bond yields spike worldwide on top of soaring debt, AI spending

Bond yields (^TYX, ^TNX, ^FVX) continue to soar on the backdrop of struggling equities (^DJI, ^IXIC, ^GSPC) and the US government's growing debt. Morning Brief Host Julie Hyman is joined by Yahoo Finance Tech Editor Dan Howley and Barron's associate editor Al Root to talk about the global factors driving this latest bond market surge.

Is Delta (DAL) a Buy as Wall Street Analysts Look Optimistic?
Zacks41d agobullish
Is Delta (DAL) a Buy as Wall Street Analysts Look Optimistic?

Based on the average brokerage recommendation (ABR), Delta (DAL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?